Research at Oslo University Hospital

 

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic rsearch, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

 

Latest news

OUH study suggesting link between maternal age and emergency delivery attracts attention

 
Lina Herstad<br>First author
Lina Herstad
First author

Lina Herstad from the Norwegian Resource Centre for Women’s Health at Woman and Children' Division at Oslo University Hospital is first author on an article recently published in BJOG, entitled "Maternal age and emergency operative deliveries at term: a population-based registry study among low-risk primiparous women."

The study used a sample of 169,583 low risk, first-time mothers in Norway to examine the association between maternal age and emergency operative delivery. The results suggest that an increased risk of emergency operative delivery is linked with increasing maternal age.

The study has attracted considerable attention, and the findings are discussed on several popular science international web sites, such as Science Daily and Science World Report.

 
 

Erik Fosse appointed "Scientist of the Month" by "Helse Sør-Øst" for July 2014

 
Erik Fosse (photo Ram Gupta)
Erik Fosse (photo Ram Gupta)

The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".

For the month of July 2014, this honour went to Erik Fosse from the Intervention Centre at the Division of Diagnostics and Intervention, Oslo University Hospital.

 
 

Myklebost and Børresen-Dale co-authors on recent Science article on mobile DNA in cancer

 
Ola Myklebost and Anne-Lise Børresen-Dale
Ola Myklebost and Anne-Lise Børresen-Dale

Ola Myklebost from the Department of Tumor Biology and Anne-Lise Børresen-Dale co-author an article published in Science (journal impact factor 31) Aug 1st, entitled "Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes".
This article described the detailed analysis of rearrangements involving L1 retrotransposons in multiple cancer types, including breast and bone cancer, based on sub studies within the framework of the International Cancer genome Consortium. Børresen-Dale’s group is a partner in the Breast Cancer Consortium, and that of Ola Myklebost in the Bone Cancer Group.

 
 

OUH-paper featured on the 2012 AACR most-cited list

 
Kyrre Emblem
Kyrre Emblem

A research paper published in 2012 in Cancer Research by Kyrre E. Emblem (Intervention Centre, OUH) as the corresponding author is highlighted by the American Association of Cancer Research (AACR) as one of the most highly-cited AACR articles from date of publication until February 2014.

 
 

Glioma treatment research project headed by Einar Vik-Mo and Iver Langmoen attracts attention

 
Einar O. Vik-Mo
Einar O. Vik-Mo

A project initiated by post doc Einar Vik-Mo and professor Iver Langmoen from the Department of Neurosurgery at OUS has drawn interest from Norwegian media. The major newspaper Aftenposten has recently presented his project in a feature article entitled "Norwegian physicians tailor make chemotherapy to each tumor".

Prospective isolation of tumour initiating cells is possible using tumour specific antigens. Vik-Mo, Langmoen and collaborators s are currently working on the isolation and characterization of such tumour initiating cells using primary cell cultures, both as floating neurosphere assays and adherent cultures, and combining this with FACS and MACS to prospectively isolate the putative tumour initiating cells.

 
 

Karin Cecilie Lødrup Carlsen appointed "Scientist of the Month" by "Helse Sør-Øst" for June 2014

 
K.C. Lødrup Carlsen
K.C. Lødrup Carlsen

The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".

For the month of June 2014, this honour went to Karin Cecilie Lødrup Carlsen from the Department of Paediatric Medicine at the Women and Children's Division, Oslo University Hospital.